查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493276

深奥测试市场规模、份额、趋势分析报告：按类型、按技术、按最终用途、按地区、细分市场预测，2024-2030 年

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing), By Technology (Chemiluminescence Immunoassay), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10个工作天内

价格

深奥测试市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球深奥测试市场规模将达到479.8亿美元，2024年至2030年复合年增长率为11.81%。

推动市场成长的主要因素包括癌症盛行率的上升以及对安全有效检测的需求不断增长。根据国际癌症研究机构的报告，2020年有19,292,789名癌症患者，预计2025年将增加至50,550,287名。最常见的癌症是乳癌、大肠癌、肺癌、摄护腺癌和胃癌。

此外，在深奥的DNA测序技术的进步的帮助下，慢性病和感染疾病病率的上升预计将进一步推动整体市场的成长。例如，根据 CDC 的数据，心臟病是美国的首要死因，每 33 秒就有一人死亡。此外，根据美国国家糖尿病统计报告，美国总人口的11.6%患有糖尿病。此类主要感染疾病的高盛行率预计将推动对深奥检测的需求。

由于高功效和特异性、高讯号强度、良好的精度和高精度等优势，人们对深奥测试的偏好不断增加，预计将推动预测期内对进阶测试的需求。此外，医生和患者对用于早期疾病诊断的深奥测试设备的认识不断增强。这一转变预计将显着提高测试采用率并推动市场成长。

此外，由于对预防性医疗保健的偏好和意识不断提高，医疗保健支出的增加正在推动市场成长。例如，在美国，《平价医疗法案》(ACA) 透过为推荐的预防性服务提供保险计划，帮助人们获得并负担医疗保健费用。此外，增加患者参与疾病管理和转向实证治疗也有助于市场成长。

同样，这些测试是识别罕见疾病的简单方法。因此，罕见疾病在人群中患病率的增加预计将推动市场扩张。据美国卫生与公众服务部称，美国新增约2,205例西尼罗河病毒感染疾病病例。感染疾病的深奥检测市场正在不断增长，因为传染病的深奥检测可以轻鬆检测出这些罕见疾病。政府资助的倡议，例如意识提升宣传活动、筛检计划和特定癌症计划，预计将增加诊断病例的数量。例如，印度卫生部长癌症患者基金（HMCPF）计划为贫困癌症患者提供财政支持。预计这将增加对深奥测试的需求并推动区域成长。

市场上经营的主要公司不断致力于开发新产品，以满足日益增长的疾病预防和早期诊断的需求。例如，2023 年 7 月，Quest Diagnostics 宣布推出消费者主导的基因测试，其独特功能包括强大的 NGS 支援服务、订购和一对一基因测试。此外，领先的公司正专注于地理扩张，以增加其影响力和获得有效产品的机会。例如，2022 年 6 月，SRL Diagnostics 在印度清奈的Ashok Nagar 开设了参考实验室。这个占地 20,000 平方英尺的实验室每月可以进行 1,000 多项测试，从广谱测试到未经证实的测试和基因测试。

深奥的测试市场报告亮点

  • 按类型划分，由于深奥检测在癌症诊断中的突出应用，肿瘤学领域预计将在 2023 年占据市场主导地位，而基因检测领域预计在预测期内将以最快的复合年增长率增长。
  • 从技术来看，化学冷光免疫检测技术领域在2023年占据市场主导地位。然而，酵素结合免疫吸附检测法预计将在预测期内显示出最快的增长。
  • 按最终用途划分，独立实验室和参考实验室部分在 2023 年占据最大份额。然而，预计医院实验室在预测期内将出现最快的成长。
  • 由于感染疾病发病率上升、政府对优质医疗保健的支持、高购买力和高效的报销方案等因素，北美在市场上占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章深奥的测试市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 深奥的测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 深奥的测验市场：按类型估算和趋势分析

  • 细分仪表板
  • 全球深奥测试市场波动分析
  • 按类型分類的全球 Esoteric 测试市场展望
  • 肿瘤检查
  • 传染病检查
  • 基因检测
  • 内分泌检查
  • 毒性试验
  • 神经学检查
  • 其他的

第五章 深奥的测试市场：技术预估与趋势分析

  • 细分仪表板
  • 全球深奥测试市场波动分析
  • 按技术分類的全球深奥测试市场前景
  • 化学冷光免疫检测
  • 酵素免疫分析法
  • 质谱
  • 即时聚合酵素链锁反应
  • 流式细胞技术
  • 其他的

第 6 章 深奥的测试市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球深奥测试市场波动分析
  • 按最终用途分類的全球深奥测试市场展望
  • 医院实验室
  • 独立参考实验室
  • 其他的

第七章 深奥测验市场：按地区估算及趋势分析

  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Laboratory Corporation of America Holdings
    • OPKO Health, Inc.
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • HU Group Holdings, Inc.
    • Kindstar Globalgene Technology, Inc.
    • Stanford Health Care
    • Mayo Foundation for Medical Education and Research
    • ARUP Laboratories.
    • Athena Esoterix
    • ACM Global Laboratories
    • Healius Limited.
Product Code: GVR-4-68040-272-6

Esoteric Testing Market Growth & Trends:

The global esoteric testing market size is anticipated to reach USD 47.98 billion by 2030, expanding at a CAGR of 11.81% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth include rising prevalence of cancer and growing need for safe and effective tests. The International Agency for Research on Cancer reports that 19,292,789 cancer cases were recorded in 2020 and estimates that number will rise to 50,550,287 by 2025. The most frequently reported cancers are breast, colorectal, lung, prostate, and stomach.

Moreover, the rising prevalence of chronic and infectious diseases aided by the advancements in esoteric DNA sequencing technologies is further anticipated to drive overall growth of the market. For instance, according to CDC, heart disease are leading cause of death in the U.S., and accounts for the death of one person every 33 seconds. Furthermore, according to the National Diabetes Statistics Report, 11.6% of the total population in the U.S. suffer from diabetes. Such a high prevalence of major infectious diseases is anticipated to drive the demand for esoteric testing.

The growing preference for esoteric testing, attributed to advantages like high efficacy and specificity, high signal intensity, good precision, and high accuracy, is projected to drive the demand for advanced tests during the forecast period. Furthermore, rising awareness of esoteric testing devices among physicians and patients for early disease diagnosis. This shift is anticipated to substantially boost the adoption of tests, thereby driving market growth.

Moreover, the rising healthcare expenditure aided with rising preference and awareness regarding preventive healthcare is fueling the growth of the market. For example, the Affordable Care Act (ACA) helps in providing accessible and affordable for people in U.S. by providing insurance plans for recommended preventive services. Additionally, the growing patient participation in disease management and the shift towards evidence-based treatment are also contributing to the growth of the market.

Similarly, these tests are a simple way to identify rare diseases. Therefore, the population's increasing incidence of rare diseases is anticipated to support market expansion. As per the U.S. Department of Health and Human Services, around 2,205 new West Nile virus disease cases in the U.S. The esoteric testing market is growing because esoteric tests for infectious diseases can easily detect these rare diseases. Government-sponsored initiatives, including awareness campaigns, screening programs, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, India's Health Minister Cancer Patient Fund (HMCPF) program financially assists deprived cancer patients. This is anticipated to increase demand for esoteric testing and promote regional growth.

Key players operating in the market are constantly focusing on development of novel products to meet the rising demand for preventive and early diseases diagnosis. For instance, in July 2023, Quest Diagnostics announced the launch of consumer-initiated genetic tests with unique feature including robust NGS support services, ordering, and access to one-on-one genetic testing. Moreover, major players are focusing on geographic expansion to enhance their presence and expand access to effective products. For instance, in June 2022, SRL Diagnostics opened a reference laboratory in Ashok Nagar, Chennai, India. The 20,000-square-foot laboratory can perform over one lakh monthly tests, ranging from widespread examinations to unidentified and genetic tests.

Esoteric Testing Market Report Highlights:

  • Based on type, the oncology segment dominated the market in 2023 owing to prominent application of esoteric testing in cancer diagnosis and genetic testing segment is expected to grow at the fastest CAGR over the forecast period
  • Based on technology, the chemiluminescence immunoassay technology segment dominated the market in 2023. However, enzyme-linked immunosorbent assay is anticipated to witness fastest growth over the forecast period
  • Based on end-use, the independent and reference laboratories segment held the largest share in 2023. However, hospital-based laboratories is anticipated to witness fastest growth over the forecast period
  • North America dominated the market owing to factors such as rising incidence of infectious diseases, government support for quality healthcare, high purchasing power, and efficient reimbursement scenario

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of infectious disease
      • 3.2.1.2. Technological advancements in esoteric testing
      • 3.2.1.3. Increasing per capita income
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of skilled healthcare professional in developing countries
      • 3.2.2.2. Stringent regulatory framework
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Esoteric Testing Market Movement Analysis
  • 4.3. Global Esoteric Testing Market by Type Outlook
  • 4.4. Oncology testing
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious disease testing
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic testing
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology testing
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology testing
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology testing
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Esoteric Testing Market Movement Analysis
  • 5.3. Global Esoteric Testing Market by Technology Outlook
  • 5.4. Chemiluminescence immunoassay
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked immunosorbent assay
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass spectrometry
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Real time polymerase chain reaction
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow cytometry
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Esoteric Testing Market Movement Analysis
  • 6.3. Global Esoteric Testing Market by End-use Outlook
  • 6.4. Hospital-based laboratories
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.5. Independent and reference laboratories
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Laboratory Corporation of America Holdings
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. OPKO Health, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Quest Diagnostics Incorporated
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sonic Healthcare Limited
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. H.U. Group Holdings, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Kindstar Globalgene Technology, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Stanford Health Care
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Mayo Foundation for Medical Education and Research
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. ARUP Laboratories.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Athena Esoterix
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. ACM Global Laboratories
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
      • 8.3.14.3. Product benchmarking
    • 8.3.14. Healius Limited.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Germany esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 South Korea esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Thailand esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 63 Latin America esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Brazil esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Esoteric Testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina surgical ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA esoteric testing market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Esoteric testing market: market outlook
  • Fig. 14 Esoteric testing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Esoteric testing market driver impact
  • Fig. 20 Esoteric testing market restraint impact
  • Fig. 21 Esoteric testing market strategic initiatives analysis
  • Fig. 22 Esoteric testing market: Type movement analysis
  • Fig. 23 Esoteric testing market: Type outlook and key takeaways
  • Fig. 24 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Infectious disease testing estimates and forecast, 2018 - 2030
  • Fig. 26 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 27 Endocrinology testing estimates and forecast, 2018 - 2030
  • Fig. 28 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 29 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 30 Others estimates and forecast, 2018 - 2030
  • Fig. 31 Esoteric testing Market: Technology movement Analysis
  • Fig. 32 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 33 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 34 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 35 Enzyme-linked immunosorbent assay market estimates and forecasts, 2018 - 2030
  • Fig. 36 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 37 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030
  • Fig. 39 Esoteric testing market: End use movement analysis
  • Fig. 40 Esoteric testing market: End use outlook and key takeaways
  • Fig. 41 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 42 Independent and reference laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030
  • Fig. 44 Global esoteric testing market: Regional movement analysis
  • Fig. 45 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 46 Global esoteric testing market share and leading players
  • Fig. 47 North America market share and leading players
  • Fig. 48 Europe market share and leading players
  • Fig. 49 Asia Pacific market share and leading players
  • Fig. 50 Latin America market share and leading players
  • Fig. 51 Middle East & Africa market share and leading players
  • Fig. 52 North America: SWOT
  • Fig. 53 Europe SWOT
  • Fig. 54 Asia Pacific SWOT
  • Fig. 55 Latin America SWOT
  • Fig. 56 MEA SWOT
  • Fig. 57 North America, by country
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecasts, 2018 - 2030
  • Fig. 60 U.S. Key Country Dynamics
  • Fig. 61 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Canada Key Country Dynamics
  • Fig. 63 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 66 UK Key Country Dynamics
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030
  • Fig. 68 Germany Key Country Dynamics
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 70 France Key Country Dynamics
  • Fig. 71 France market estimates and forecasts, 2018 - 2030
  • Fig. 72 Italy Key Country Dynamics
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 74 Spain Key Country Dynamics
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 76 Denmark Key Country Dynamics
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 78 Sweden Key Country Dynamics
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 80 Norway Key Country Dynamics
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 84 China Key Country Dynamics
  • Fig. 85 China market estimates and forecasts, 2018 - 2030
  • Fig. 86 Japan Key Country Dynamics
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 88 India Key Country Dynamics
  • Fig. 89 India market estimates and forecasts, 2018 - 2030
  • Fig. 90 Thailand Key Country Dynamics
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 92 South Korea Key Country Dynamics
  • Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 94 Australia Key Country Dynamics
  • Fig. 95 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 98 Brazil Key Country Dynamics
  • Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 100 Mexico Key Country Dynamics
  • Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 102 Argentina Key Country Dynamics
  • Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 104 Middle East and Africa
  • Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 106 South Africa Key Country Dynamics
  • Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 Saudi Arabia Key Country Dynamics
  • Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 110 UAE Key Country Dynamics
  • Fig. 111 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 112 Kuwait Key Country Dynamics
  • Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 114 Market share of key market players- esoteric testing market